Dennis Rose

Dennis Rose is an experienced professional in pharmaceutical and healthcare operations, currently serving as Vice President of Operations at NephroDI Therapeutics, Inc. since July 2023. NephroDI Therapeutics focuses on developing an oral drug for Nephrogenic Diabetes Insipidus (NDI) in pediatric patients. Prior to this role, Dennis worked at Hyland as a Program Manager from January 2020 to July 2023 and held the position of Project Manager with the same company from October 2015 to July 2023. Earlier experience includes project management roles at Influence Health, Ascension Health, and a tenure as Assistant Director at CPSI from 2005 to 2008.